查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲新生兒篩檢市場預測至 2030 年 - 區域分析 - 按產品類型（試劑和檢測試劑盒及儀器）、技術、測試類型和最終用戶（醫院和診所以及診斷實驗室）
市場調查報告書
商品編碼
1463688

歐洲新生兒篩檢市場預測至 2030 年 - 區域分析 - 按產品類型（試劑和檢測試劑盒及儀器）、技術、測試類型和最終用戶（醫院和診所以及診斷實驗室）

Europe Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日期: | 出版商: The Insight Partners | 英文 108 Pages | 訂單完成後即時交付

價格

2022年歐洲新生兒篩檢市場價值為3.2804億美元，預計到2030年將達到6.5383億美元；預計 2022 年至 2030 年複合CAGR為 9.0%。

先天性疾病負擔的增加推動了歐洲新生兒篩檢市場的發展。

如果不及早發現和治療，先天性疾病可能會導致終生健康挑戰。這些疾病可能導致長期殘疾，嚴重影響家庭、個人、醫療保健系統和社會。世界衛生組織估計，全世界每年有 24 萬名新生兒在出生後 28 天內死於這些疾病。另有 17 萬名 1 個月至 5 歲兒童因先天性疾病死亡。對許多先天性疾病的遺傳基礎的日益了解是導致這些疾病負擔日益增加的幾個因素之一。基因組學和基因檢測的進步使醫療保健提供者能夠識別新生兒更廣泛的基因突變和病症。這種擴展的知識凸顯了透過新生兒篩檢進行早期診斷以及時採取干涉和治療的重要性。

母親年齡、環境暴露和生活習慣改變等人口統計的變化會增加新生兒先天性疾病的風險。此外，由於全球人口迅速成長，每天的出生人數不斷增加，導致患有先天性疾病風險的嬰兒數量不斷增加。此外，醫療保健系統和政策制定者認知到早期疾病檢測的長期好處。他們擴大將新生兒篩檢納入常規醫療保健方案和保險範圍，進一步刺激市場成長。先天性疾病負擔的增加是新生兒篩檢市場成長的重要動力。

歐洲新生兒篩檢市場概況

歐洲新生兒篩檢市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。歐洲新生兒篩檢市場的成長是由醫療保健支出增加以及先天性疾病、新生兒疾病和其他新生兒疾病發病率激增所推動的。醫學研究技術的發展以及用於早期發現疾病的多種診斷篩檢程序也使歐洲市場受益。隨著政府和非政府組織正在製定加強母嬰保育的措施，整個地區的新生兒篩檢計畫數量預計將迅速增加。根據 NCBI 2022 年的資訊，預計篩檢每年將使歐盟約 4,000 名兒童受益。創新診斷方法（例如 MS/MS 和分子技術）、治療選擇（例如基因療法和酶替代療法）的發展以及對罕見疾病的了解的加深正在推動新生兒篩檢計畫的擴展。

歐洲國家的醫療保健提供者正在提供全面的新生兒篩檢小組，涵蓋更廣泛的遺傳和代謝狀況。幾個歐洲國家的醫療保健當局實施了強制性新生兒篩檢計劃，確保每個新生兒在出生後不久就接受必要的篩檢。根據 NCBI 2023 年發布的資料，脊髓性肌肉萎縮症和嚴重聯合免疫缺陷 (SCID) 篩檢都在快速發展；挪威、德國和其他歐洲國家計劃從 2021 年和 2022 年起將 SMA 篩檢納入其國家篩檢計畫。許多其他國家已經開始實施區域試點計畫。 SCID 篩檢剛剛在捷克共和國啟動。這種立法支持增加了篩檢測試的總量，並為篩檢服務提供者創造了一個穩定且可預測的市場。

歐洲新生兒篩檢市場收入及 2030 年預測（百萬美元）

歐洲新生兒篩檢市場細分

歐洲新生兒篩檢市場根據產品類型、技術、測試類型、最終用戶和國家進行細分。

根據產品類型，歐洲新生兒篩檢市場分為試劑、檢測試劑盒和儀器。到 2022 年，試劑和檢測試劑盒細分市場將佔據更大的歐洲新生兒篩檢市場佔有率。儀器部分細分為新生兒疾病篩檢儀器、脈搏血氧儀、新生兒聽力篩檢儀器和其他儀器。

從技術面來看，歐洲新生兒篩檢市場分為串聯質譜（TMS）、分子檢測、免疫檢測和酵素檢測、脈搏血氧篩檢技術等技術。 2022 年，脈搏血氧儀篩檢技術領域佔據歐洲最大的新生兒篩檢市場。

根據測試類型，歐洲新生兒篩檢市場分為乾血斑測試、聽力篩檢測試、危重先天性心臟病（CCHD）測試和其他測試類型。 2022 年，乾血斑檢測領域佔據歐洲最大的新生兒篩檢市場。

依最終用戶分類，歐洲新生兒篩檢市場分為醫院、診所和診斷實驗室。到 2022 年，醫院和診所細分市場將佔據更大的歐洲新生兒篩檢市場。

按國家/地區分類，歐洲新生兒篩檢市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022年，法國在歐洲新生兒篩檢市場佔據主導地位。

Bio-Rad Laboratories Inc、Masimo Corp、Medtronic Plc、MRC Holland BV、Natus Medical Inc、PerkinElmer Inc、Waters Corp 和 Zentech SA 是歐洲新生兒篩檢市場上的一些領先公司。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲新生兒篩檢市場 - 主要產業動態

  • 主要市場促進因素
    • 政府為新生兒篩檢提供的資金激增
    • 先天性疾病負擔不斷增加
    • 新生兒疾病盛行率不斷增加
  • 主要市場限制
    • 新生兒篩檢政策和實踐缺乏統一
  • 主要市場機會
    • 新生兒基因篩檢
  • 未來的趨勢
    • 機器學習和人工智慧在篩檢中的整合
  • 影響分析：

第 5 章：新生兒篩檢市場 - 歐洲市場分析

  • 歐洲新生兒篩檢市場收入，2022 - 2030

第 6 章：歐洲新生兒篩檢市場 - 2030 年收入和預測 - 按產品類型

  • 概述
  • 2022 年和 2030 年歐洲新生兒篩檢市場收入佔有率（按產品類型分類）
  • 試劑和檢測試劑盒
  • 儀器

第 7 章：歐洲新生兒篩檢市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年和 2030 年歐洲新生兒篩檢市場收入佔有率（按技術分類）
  • 串聯質譜 (TMS)
  • 分子檢測
  • 免疫測定和酵素測定
  • 脈搏血氧篩檢技術
  • 其他技術

第 8 章：歐洲新生兒篩檢市場 - 2030 年收入和預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年歐洲新生兒篩檢市場收入佔有率，按測試類型分類 (%)
  • 乾血斑測試
  • 聽力篩檢測試
  • 嚴重先天性心臟病 (CCHD) 測試
  • 其他測試類型

第 9 章：歐洲新生兒篩檢市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年歐洲新生兒篩檢市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診所
  • 診斷實驗室

第 10 章：歐洲新生兒篩檢市場 - 國家分析

  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 11 章：歐洲新生兒篩檢市場-產業格局

  • 概述
  • 新生兒篩檢市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Zentech SA
  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • MRC Holland BV
  • Medtronic Plc

第 13 章：附錄

Product Code: BMIRE00029604

The Europe newborn screening market was valued at US$ 328.04 million in 2022 and is expected to reach US$ 653.83 million by 2030; it is estimated to grow at a CAGR of 9.0% from 2022 to 2030.

Rising Burden of Congenital Diseases Fuels the Europe Newborn Screening Market.

Congenital diseases can lead to lifelong health challenges if not detected and managed early. These diseases can contribute to long-term disability, significantly affecting families, individuals, healthcare systems, and societies. The WHO estimates that 240,000 newborns worldwide succumb to death each year within 28 days of birth due to these diseases. An additional 170,000 children die between the age of 1 month and 5 years due to congenital diseases. A growing understanding of the genetic basis of many congenital diseases is one of the several factors contributing to the increasing burden of these conditions. Advancements in genomics and genetic testing have enabled healthcare providers to identify a broader range of genetic mutations and conditions in newborns. This expanded knowledge has highlighted the importance of early diagnosis through newborn screening to initiate timely interventions and treatments.

Changing demographics such as maternal age, environmental exposures, and altering lifestyle habits increase the risk of congenital conditions in newborns. Moreover, the number of births occurring every day is on the rise due to the burgeoning global population, resulting in an expanding pool of infants that can be at risk of congenital diseases. In addition, healthcare systems and policymakers recognize the long-term benefits of early disease detection. They increasingly incorporate newborn screening into routine healthcare protocols and insurance coverage, further stimulating market growth. The rising burden of congenital diseases is a significant driver behind the growth of the newborn screening market.

Europe Newborn Screening Market Overview

The European newborn screening market is segmented into Germany, the UK, France, Italy, Spain , and the Rest of Europe. Growth of the newborn screening market in Europe is driven by increased healthcare spending and an upsurge in the occurrence of congenital diseases, neonatal diseases, and other newborn diseases. Developments in techniques employed in medical research and several diagnostic screening procedures for the early detection of illnesses are also benefiting the market in Europe. The number of newborn screening programs across the region is expected to increase rapidly as government and nongovernment organizations are developing measures to enhance mother-childcare. According to information by NCBI in 2022, screening is anticipated to benefit ~4,000 children annually in the EU. The development of innovative diagnostic methods (such as MS/MS and molecular technologies), therapeutic options (such as gene therapy and enzyme replacement therapies), and increased understanding of rare diseases are driving the expansion of newborn screening programs.

Healthcare providers in European countries are offering comprehensive newborn screening panels, encompassing a broader spectrum of genetic and metabolic conditions. Healthcare authorities in several European countries have implemented mandatory newborn screening programs, ensuring every newborn undergoes essential screenings shortly after birth. As per a data published by NCBI in 2023, both spinal muscular atrophy and severe combined immunodeficiency (SCID) screening are evolving quickly; Norway, Germany, and other European countries had plans to include SMA screening in their national screening programs from 2021 and 2022 onward. Regional pilot programs are already underway in many other nations. SCID screening was just launched in the Czech Republic. This legislative support has increased the overall volume of screening tests and created a stable and predictable market for screening service providers.

Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

Europe Newborn Screening Market Segmentation

The Europe newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the Europe newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger Europe newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Europe newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest Europe newborn screening market share in 2022.

Based on test type, the Europe newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest Europe newborn screening market share in 2022.

By end user, the Europe newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger Europe newborn screening market share in 2022.

By country, the Europe newborn screening market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe newborn screening market in 2022.

Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, MRC Holland BV, Natus Medical Inc, PerkinElmer Inc, Waters Corp, and Zentech SA are some of the leading companies operating in the Europe newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - Europe Market Analysis

  • 5.1 Europe Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 Europe Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Europe Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Europe Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 Europe Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 Europe Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Europe Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Newborn Screening Market - Country Analysis

  • 10.1 Europe Newborn Screening Market
    • 10.1.1 Europe Newborn Screening Market, by Country
      • 10.1.1.1 UK
        • 10.1.1.1.1 UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 UK: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.1 UK: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.2 UK: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.3 UK: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.1.4 UK: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 UK: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Germany: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 Germany: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.2 Germany: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Germany: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Germany: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Germany: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 France
        • 10.1.1.3.1 France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 France: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 France: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.2 France: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.3 France: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.3.4 France: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 France: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.4 Italy
        • 10.1.1.4.1 Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Italy: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2.1 Italy: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2.2 Italy: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Italy: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Italy: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.5 Italy: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.5 Spain
        • 10.1.1.5.1 Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.2 Spain: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.2.1 Spain: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.2.2 Spain: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.5.3 Spain: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.5.4 Spain: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.5.5 Spain: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Europe
        • 10.1.1.6.1 Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.2 Rest of Europe: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2.1 Rest of Europe: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2.2 Rest of Europe: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. Europe Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zentech SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 PerkinElmer Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Waters Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Masimo Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Natus Medical Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 MRC Holland BV
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Newborn Screening Market Segmentation
  • Table 2. Europe Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Europe Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. UK Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. UK Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. UK Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. UK Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. UK Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Germany Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Germany Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Germany Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Germany Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Germany Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Germany Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. France Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. France Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. France Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. France Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. France Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. France Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Italy Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Italy Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Italy Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Italy Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Italy Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Spain Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Spain Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Spain Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Spain Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Spain Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Europe Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Europe Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Rest of Europe Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 41. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 42. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. Europe Newborn Screening Market Segmentation, By Country
  • Figure 2. Europe Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Europe Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Europe Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: Europe Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Europe Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. UK Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Germany Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. France Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Italy Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Spain Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Europe Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Newborn Screening Market